Taiwan To Continue Listing Some Vitamins as Drug Products
This article was originally published in PharmAsia News
Taiwan's health department says it will continue listing certain vitamins and other treatments as drug products. The Department of Health currently lists vitamins that are injected, have a high dosage, are single prescriptions or claim treatment effects. As an example, officials cited vitamin D as a natural substance, but D3 is not, so a calcium tablet with that element is regarded as a drug product. The decision was announced at a meeting with experts on listing vitamins as food products. (Click here for more
You may also be interested in...
AdvaMed’s VentConnect platform is expanding to support production of devices needed to treat COVID-19. Here’s what Eric Fanning, CEO of participating group the Aerospace Industries Association, said about the move.
Preliminary plans for an Oct. 22 meeting of US FDA's vaccine advisory committee suggest a fast evaluation of COVID-19 immunizations, bringing mixed reactions from onlookers who say it could be a positive sign of needed public transparency or an indication the agency is rushing to approve a product ahead of the November presidential election.
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.